DVA vs STRO
DaVita HealthCare Partners Inc (DVA) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. STRO currently screens at market cap $470.8M.
Not investment advice. Open the DVA and STRO stock pages for the full models.
Not investment advice.